Hematological Disorders in Covid 19 Patients
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 主要终点
- Hematological disorders in covid 19 patients
研究概览
简要总结
aim of the research is to detect hematological abnormalities in covid 19 patients and its correlation with the severity and outcome of the disease.
详细描述
Covid 19 is an infectious disease caused by a newly discovered coronavirus.most people infected with the covid 19 virus will have mild to moderate respiratory illness and recover without specific treatment.older people and those with underlying medical problems like cardiac diseases,diabetes,any chronic respiratory disease and cancer are more likely to have serious illness.the covid 19 virus spreads primarily through droplets of saliva or discharge from the nose oral cavity when an infected person coughs or sneezes.people with covid19 have had a wide range of symptoms reported _ranging from mild to severe symptoms.symptoms may appear 2_14 days after exposure to the infection .any one can have mild to severe symptoms.people with these symptoms may have covid 19: fever or shivering,cough,shortness of breath,fatigue,body or muscle aches,headache,new loss of smell or taste ,sore thraot,congestion or running nose , nausea or vomiting,diarrhoea.
The most common hematological clinical findings include lymphocytopenia,neutrophilia,eosinophilia,mild thrombocytopenia,and less frequently thrombocytosis,the presence of reactive lymphocytes has been reported only occasionally the leucocyte count may be normal,reduced or increased.according to a meta analysis leucocytosis,lymphopenia and thrombocytopenia are associated with greater severity and fatality in covid 19 cases
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all covid 19 patients diagnosed by pcr or CT chest
排除标准
- 未提供
结局指标
主要结局
Hematological disorders in covid 19 patients
时间窗: Baseline
to detect hematological abnormalities in covid 19 patients and its correlation to outcome and severity of the disease
次要结局
未报告次要终点
研究者
Radwa mahmoud elsayed
Dr/Radwa mahmoud elsayed
Assiut University
